ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101. A total of 89 filers reported holding ADURO BIOTECH INC in Q2 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $679,000 | -31.2% | 640,595 | 0.0% | 0.06% | -74.2% |
Q2 2019 | $987,000 | -61.3% | 640,595 | 0.0% | 0.24% | -62.3% |
Q1 2019 | $2,550,000 | +50.8% | 640,595 | 0.0% | 0.65% | +81.7% |
Q4 2018 | $1,691,000 | -64.1% | 640,595 | 0.0% | 0.36% | -70.4% |
Q3 2018 | $4,708,000 | +5.0% | 640,595 | 0.0% | 1.20% | +13.0% |
Q2 2018 | $4,484,000 | -67.3% | 640,595 | -56.6% | 1.06% | -36.7% |
Q1 2018 | $13,712,000 | -56.2% | 1,474,444 | -64.7% | 1.68% | -93.9% |
Q4 2017 | $31,293,000 | -54.9% | 4,172,449 | -36.0% | 27.41% | +301.3% |
Q3 2017 | $69,418,000 | – | 6,518,100 | – | 6.83% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARVARD MANAGEMENT CO INC | 640,595 | $4,708,000 | 1.20% |
BVF INC/IL | 287,776 | $2,115,000 | 0.19% |
ORACLE INVESTMENT MANAGEMENT INC | 111,542 | $820,000 | 0.18% |
Sofinnova Investments, Inc. | 189,579 | $1,393,000 | 0.12% |
CENTAURUS FINANCIAL, INC. | 85 | $624,000 | 0.11% |
Artal Group S.A. | 550,000 | $4,043,000 | 0.10% |
Vident Investment Advisory, LLC | 305,311 | $2,244,000 | 0.09% |
Virtus ETF Advisers LLC | 61,463 | $452,000 | 0.05% |
Foundry Partners, LLC | 106,907 | $786,000 | 0.03% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 239,301 | $1,759,000 | 0.02% |